AHA 2017 Scientific Sessions
Direct Oral Anticoagulant Use Increasing in Dialysis Patients With AFib
End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.
Your search for Warfarin returned 6 results
ESC 2017
Bleeding Risk Reduced with Dabigatran Dual Tx vs. Warfarin Triple Tx
The primary safety endpoint was defined as time to major bleeding events and clinically relevant non-major bleeding events when compared to triple therapy with warfarin.
ACC.17
Anticoagulants Compared in A-fib Patients Undergoing Catheter Ablation
Study patients were randomized to Pradaxa 150mg twice daily or warfarin (target INR 2-3) and remained on this treatment for the trial duration.
ACC.17
Edoxaban Use May be Safe for Patients Undergoing A-fib Ablation
Jan Steffel, from the TIMI Study Group, Boston, MA, and colleagues presented on the safety of edoxaban in the context of atrial fibrillation (AF) ablation.
AHA 2015
Apixaban Efficacy, Safety Evaluated in AF Patient on Multiple Concomitant Medications
Older patients, females, and those with comorbidities were more likely to be on multiple medications.
American College of Cardiology 2013
Dabigatran Safe and Effective Post-Atrial Fibrillation Ablation
At ACC.13, the American College of Cardiology's 62nd Annual Scientific Session, leading cardiologists presented that the use of dabigatran following ablation for atrial fibrillation resulted in no major post-procedural complications.
